Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

[Hemolysis and red cell deformability during cardiopulmonary bypass--the effect of prostaglandin E1 for prevention of hemolysis]

[Hemolysis and red cell deformability during cardiopulmonary bypass--the effect of prostaglandin E1 for prevention of hemolysis] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • [Hemolysis and red cell deformability during cardiopulmonary bypass--the effect of prostaglandin E1 for prevention of hemolysis] Abstract Text:

    h yamaguchiH Yamaguchi,t shimizuT Shimizu,h akutsuH Akutsu,k kawachiK Kawachi,k osadaK Osada,t fujikawaT Fujikawa,h suesadaH Suesada,t hirayamaT Hirayama,s ishimaruS Ishimaru,k furukawaK Furukawa,

    Prevention of hemolysis which is related to renal failure during cardiopulmonary bypass (CPB) is very important. We discussed the relationship between hemolysis and red cell deformability during CPB, and moreover the effect of PGE1 to reduce hemolysis. PGE1 was given during CPB (10 approximately 20 ng/kg/min). Red cell deformability was measured using 20% Ht red cell suspension and Nucleopore Microfilter (pore size: 5 mu). Red cell filtration rate (RFR: microliter/sec) was calculated as a value of red cell deformability. Red cell deformability (RFR: microliter/sec) was reduced during CPB in almost all patients. Secondly, plasma Hb (mg/dl) was measured in the controls (n = 8) and PGE1 group (n = 12). The mean pre-bypass level were 20.6 in the control group and 23.8 in the PGE1 group. The mean values of plasma Hb at 30, 60, 90 and 120 min of CPB were 37.8, 52.4, 52.3 and 61.2 in the control group and 24.1, 25.0, 26.3 and 29.0 in the PGE1 group. Our study showed conclusively that CPB has a detrimental effect on red cell deformability and that this effect is accentuated by prolongation of CPB time. PGE1 lessened the decrease in red cell deformability during CPB and was shown to be very effective for prevention of hemolysis.

    [Hemolysis and red cell deformability during cardiopulmonary bypass--the effect of prostaglandin E1 for prevention of hemolysis] Publishing Authors By Initials

    h yamaguchiH Yamaguchi,t shimizuT Shimizu,h akutsuH Akutsu,k kawachiK Kawachi,k osadaK Osada,t fujikawaT Fujikawa,h suesadaH Suesada,t hirayamaT Hirayama,s ishimaruS Ishimaru,k furukawaK Furukawa,

    For similar surgical procedures, operative: intraoperative period research abstracts see: surgical procedures, operative: intraoperative period research

    PUBMED ID PMID:

    MEDLINE DATE:

    [Hemolysis and red cell deformability during cardiopulmonary bypass--the effect of prostaglandin E1 for prevention of hemolysis] Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: [Zasshi] [Journal]. Nihon Ky?bu Geka Gakkai

    VOLUME: 38

    Page Numbers: 625-9

    Journal Abbreviation:

    ISSN: 0369-4739

    DAY: 14

    MONTH: Apr

    YEAR: 1990

    [Hemolysis and red cell deformability during cardiopulmonary bypass--the effect of prostaglandin E1 for prevention of hemolysis] Information

    Number of References:

    LANGUAGE: jpn

    NlmUniqueID: 19130180

    [Hemolysis and red cell deformability during cardiopulmonary bypass--the effect of prostaglandin E1 for prevention of hemolysis] Keywords Mesh Terms:

    KEYWORDS: Intraoperative Period

    MESH TERMS: drug effects

    Chemical & Substance for Abstract: [Hemolysis and red cell deformability during cardiopulmonary bypass--the effect of prostaglandin E1 for prevention of hemolysis] Information

    Substance Name: Alprostadil

    Registry Number: 745-65-3

    Grant and Affiliation Information for [Hemolysis and red cell deformability during cardiopulmonary bypass--the effect of prostaglandin E1 for prevention of hemolysis]

    AFFILIATION: Department of Surgery, Tokyo Medical College, Japan.

    Country: JAPAN

    JAPAN Research PublicationJAPAN Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Nippon Kyobu Geka Gakkai Zassh

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Hemolysis and red cell deformability during cardiopulmonary bypass--the effect of prostaglandin E1 for prevention of hemolysis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News